Michael Burshtine, MBA, CPA
Bioblast Pharma Board of Directors Member
Michael (Mike) Burshtine joined the Bioblast Pharma Board of Directors in September 2014. Mr. Burshtine has served as the President and Chief Executive Officer of Flight Medical Innovations Ltd., a med-tech company specializing in the development, manufacturing, and marketing of portable ventilators, between 2009 and May 2014. From 2007 to 2009, he served as President and Chief Executive Officer of Recoly N.V., a bio-med company engaged in the research, development, and commercialization of drug enhancement technologies. From 2004 to 2007, Mr. Burshtine served as the Chief Financial Officer of Omrix Biopharmaceuticals Inc., a public biotechnology company that develops, manufactures, and commercializes plasma derivative products. He has been a certified CPA since 1994 and was a senior partner at Kesselman & Kesselman PricewaterhouseCoopers (PWC) auditing firm until 2004.
Mr. Burshtine holds an MBA and a BA in economics and accounting, both from Tel Aviv University.Learn about other members of the Board of Directors of Bioblast